| Retinal ischemia: mechanisms of damage and potential therapeutic strategies NN Osborne, RJ Casson, JPM Wood, G Chidlow, M Graham, J Melena Progress in retinal and eye research 23 (1), 91-147, 2004 | 1125 | 2004 |
| Definition of glaucoma: clinical and experimental concepts RJ Casson, G Chidlow, JPM Wood, JG Crowston, I Goldberg Clinical & experimental ophthalmology 40 (4), 341-349, 2012 | 621 | 2012 |
| Neuroprotection in relation to retinal ischemia and relevance to glaucoma NN Osborne, M Ugarte, M Chao, G Chidlow, JH Bae, JPM Wood, ... Survey of ophthalmology 43, S102-S128, 1999 | 539 | 1999 |
| Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1 KP Burdon, S Macgregor, AW Hewitt, S Sharma, G Chidlow, RA Mills, ... Nature genetics 43 (6), 574-578, 2011 | 464 | 2011 |
| Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity R Mahajan, DH Lau, AG Brooks, NJ Shipp, J Manavis, JPM Wood, ... Journal of the American College of Cardiology 66 (1), 1-11, 2015 | 444 | 2015 |
| A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma NN Osborne, J Melena, G Chidlow, JPM Wood British Journal of Ophthalmology 85 (10), 1252-1259, 2001 | 243 | 2001 |
| Ganglion cell death in glaucoma: what do we really know? NN Osborne, JPM Wood, G Chidlow, JH Bae, J Melena, MS Nash British Journal of Ophthalmology 83 (8), 980-986, 1999 | 235 | 1999 |
| Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury A Ebneter, RJ Casson, JPM Wood, G Chidlow Investigative ophthalmology & visual science 51 (12), 6448-6460, 2010 | 214 | 2010 |
| Recharacterization of the RGC-5 retinal ganglion cell line NJ Van Bergen, JPM Wood, G Chidlow, IA Trounce, RJ Casson, WK Ju, ... Investigative ophthalmology & visual science 50 (9), 4267-4272, 2009 | 212 | 2009 |
| A review of the mechanisms of cone degeneration in retinitis pigmentosa DS Narayan, JPM Wood, G Chidlow, RJ Casson Acta ophthalmologica 94 (8), 748-754, 2016 | 175 | 2016 |
| The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma G Chidlow, A Ebneter, JPM Wood, RJ Casson Acta neuropathologica 121, 737-751, 2011 | 173 | 2011 |
| Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina NN Osborne, L DeSantis, JH Bae, M Ugarte, JPM Wood, MS Nash, ... Experimental eye research 69 (3), 331-342, 1999 | 155 | 1999 |
| A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies NN Osborne, G Lascaratos, AJ Bron, G Chidlow, JPM Wood British journal of ophthalmology 90 (2), 237-241, 2006 | 153 | 2006 |
| Optic nerve and neuroprotection strategies NN Osborne, G Chidlow, CJ Layton, JPM Wood, RJ Casson, J Melena Eye 18 (11), 1075-1084, 2004 | 152 | 2004 |
| Pharmacological neuroprotection for glaucoma G Chidlow, JPM Wood, RJ Casson Drugs 67, 725-759, 2007 | 149 | 2007 |
| Cancer‐like metabolism of the mammalian retina SK Ng, JPM Wood, G Chidlow, G Han, T Kittipassorn, DJ Peet, RJ Casson Clinical & experimental ophthalmology 43 (4), 367-376, 2015 | 136 | 2015 |
| α-Lipoic acid protects the retina against ischemia-reperfusion G Chidlow, KG Schmidt, JPM Wood, J Melena, NN Osborne Neuropharmacology 43 (6), 1015-1025, 2002 | 132 | 2002 |
| The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol JPM Wood, KG Schmidt, J Melena, G Chidlow, H Allmeier, NN Osborne Experimental eye research 76 (4), 505-516, 2003 | 126 | 2003 |
| The potential of neuroprotection in glaucoma treatment NN Osborne, G Chidlow, MS Nash, JPM Wood Current opinion in ophthalmology 10 (2), 82-92, 1999 | 115 | 1999 |
| Retinal pigment epithelium in the pathogenesis of age‐related macular degeneration and photobiomodulation as a potential therapy? J Ao, JPM Wood, G Chidlow, MC Gillies, RJ Casson Clinical & experimental ophthalmology 46 (6), 670-686, 2018 | 109 | 2018 |
